Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|June 18, 2020
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell TransplantationLia Minculescu, Anne Fischer-Nielsen, Eva Haastrup, et al.Acta Haematologica|October 12, 2023
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell TransplantationLia Minculescu, Joanne Reekie, Soeren Lykke Petersen, et al.Trials|March 9, 2017
First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trialChristian Grønhøj, David H Jensen, Peter V Glovinski, et al.Cytotherapy|November 27, 2016
Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentratesPeter V Glovinski, Mikkel Herly, Anders B Mathiasen, et al.Frontiers in Immunology|September 12, 2019
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell TransplantationLia Minculescu, Hanne Vibeke Marquart, Lars Peter Ryder, et al.Journal of Clinical Apheresis|August 24, 2017
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donorsSimon Pahnke, Gunnar Larfors, Ulla Axdorph-Nygell, et al.Communications Medicine|December 10, 2022
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patientsCharlotte Duch Lynggaard, Rosa Jersie-Christensen, Morten Juhl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized TrialCharlotte Duch Lynggaard, Christian Grønhøj, Siri B Jensen, et al.Stem Cells International|January 16, 2018
Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled StudyAbbas Ali Qayyum, Anders Bruun Mathiasen, Naja Dam Mygind, et al.Stem Cell Reviews and Reports|March 2, 2024
Mesenchymal Stromal/Stem Cell Therapy Improves Salivary Flow Rate in Radiation-Induced Salivary Gland Hypofunction in Preclinical in vivo Models: A Systematic Review and Meta-AnalysisAmanda-Louise Fenger Carlander, Anders Kierkegaard Gundestrup, Per Marcus Jansson, et al.Pageof 5